e-learning
resources
Virtual 2020
Pre-Congress Content
From pathophysiology to clinical consequences of sleep and breathing disorders
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sleep-induced HRV changes and OSA in the ESADA cohort
C. Lombardi (Milano, Italy), A. Faini (Milano, Italy), P. Castiglioni (Milano, Italy), E. Perger (Milano, Italy), L. Grote (Gothenburg, Sweden), J. Verbraecken (Anwerp, Belgium), G. Parati (Milano, Italy)
Source:
Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Session:
From pathophysiology to clinical consequences of sleep and breathing disorders
Session type:
E-poster session
Number:
2549
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lombardi (Milano, Italy), A. Faini (Milano, Italy), P. Castiglioni (Milano, Italy), E. Perger (Milano, Italy), L. Grote (Gothenburg, Sweden), J. Verbraecken (Anwerp, Belgium), G. Parati (Milano, Italy). Sleep-induced HRV changes and OSA in the ESADA cohort. 2549
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Evaluation of polysomnographic data in OSAS patients with cardiac diseases
Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea
Year: 2009
Timely association between obstructive sleep apnea (OSA) and cardiovascular outcome after first acute myocardial infarction (AMI): A national wide population-based study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016
Arterial stiffness in obese CPAP-treated obstructive sleep apnea (OSA): A seven years prospective longitudinal study
Source: International Congress 2017 – CPAP therapy
Year: 2017
Pulse wave amplitude variations: a new biomarker of cardiovascular risk in patients with obstructive sleep apnea in HypnoLaus and ISAACC cohorts
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021
Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients
Source: Eur Respir J 2003 Dec 01;22(6):943-950
Year: 2003
Gender variations regarding long term effect of CPAP on blood pressure in hypertensive patients with obstructive sleep apnea. A prospective study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Sleep apnoea severity independently predicts glycaemic health in nondiabetic subjects: the ESADA study
Source: Eur Respir J 2014; 44: 130-139
Year: 2014
Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort study
Source: ERJ Open Res, 6 (3) 00057-2020; 10.1183/23120541.00057-2020
Year: 2020
Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
Pulse wave analysis but not polysomnography recognizes sleep apnoea patients with increased cardiovascular risk
Source: International Congress 2017 – Diagnostic approaches to obstructive sleep apnoea
Year: 2017
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015
LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016
Prevalence and characteristics of insomnia phenotype in mild sleep apnoea patients from the ESADA study population.
Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea
Year: 2017
REM-associated sleep apnoea: prevalence and clinical significance in the HypnoLaus cohort
Source: Eur Respir J, 52 (2) 1702484; 10.1183/13993003.02484-2017
Year: 2018
Ventilatory phenotypes of sleep apnoea subtypes at a chronic delay following a first ischemic stroke: a cross-sectional analysis of a prospective clinical-based cohort study
Source: Sleep and Breathing Conference 2021
Year: 2021
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Gender differences in sleep apnoea syndrome in obese snoring patients: prevalence and associated clinical,functional and oxymetric data
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003
Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study
Source: Eur Respir J, 49 (6) 1601361; 10.1183/13993003.01361-2016
Year: 2017
Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study
Source: Eur Respir J 2011; 38: 1349-1354
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept